University of Charleston
Faruk Khan
Contact Info

mdomarkhan@ucwv.edu

304-357-4859

Interim Dean of the School of Pharmacy

  • POSTDOCTORAL TRAINING Sep 2004-Dec 2006: Research Associate/Adjunct Faculty, Medicinal Chemistry, Florida A & M University College of Pharmacy June 2002-Sep 2004: Postdoctoral Research Associate, University of Mississippi School of Pharmacy Oct 2001-Mar 2002: JSPS Postdoctoral Fellow (Supervisor: Prof. E. Kimura), Hiroshima University School of Pharmacy (Japan)
  • EDUCATION Aug 2011-Dec 2013: MBA. Southwestern Oklahoma State University Sep 1995-Mar 1999: PhD. University of Manchester, UK. Medicinal Chemistry and Rational Drug Design; Dissertation: Antiparasitic Drug Design Based on Trypanothione Reductase as a Target. 1989-1991: MPharm. Dhaka University, Dhaka, Bangladesh, Dissertation: Antifertility Principles from Marsdenia tinctoria. 1985-1989: BPharm (Hons). Dhaka University, Dhaka, Bangladesh.

1.         Collaborative Research

  • Fellow, AACP Academic Research Fellows Program (ARFP) 2013-14. It is a year-long program designed to expand the leadership capabilities of established faculty research scientists or administrators to cultivate collaborative team research and graduate education across institutions. I gained experience in research-focused leadership development; team building; development of innovative research strategies to secure funding from federal and other public and private sources. I also gained insight into the dynamics, management, institutional structures and policies that affect research teams; and have the opportunity to network with successful research leaders and advocacy groups and finally participated in a collaborative group project.
  • Antibreast cancer drug discovery in collaboration with Drs H Koc, DPSR and E Koc SoM.
  • Antiparasitic drug discovery research in collaboration with Dr. Babu Tekwani, Principal Scientist and Professor of Pharmacology, University of Mississippi under a material transfer agreement.
  • I am also an important contributor and active collaborator for the research in the area of anti-breast cancer drug discovery with Dr. Musa, assistant professor of Department of Chemistry of Florida A&M University.
  • Dr. Taufiq Ur Rahman, Lecturer, University of Cambridge, UK, who is conducting the molecular modeling studies against estrogen receptor for our research activity in the area of breast cancer. We have already published one paper that included his docking study results.
  • Dr. Tim Hubin, Professor of Chemistry, Southwestern Oklahoma State University. Numerous collaborative researches are underway in the area of anti-infective drug discovery based on macrocyclic polyamine derivatives. Multiple high impact research articles and one patent has been produced. A material transfer agreement has been created.
  • Dr. Jennifer Keiser, Helminth Drug Development Unit, Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland. We published a research article on anti-schistosomiasis drug discovery.

2.         Professional And Scientific Meetings

  1. August 17 & 18, 2018. WVPA’s 111th Annual Convention. Charleston Marriott Hotel, Charleston, WV.
  2. August 16-17, 2018. SAMHSA Region III IPEC Summit: Enhancing Addiction Education Across the Health Professions. Association of American Medical Colleges (AAMC) Learning Center in Washington, DC.
  3. July 21-25, 2018. AACP Annual Meeting, Pharmacy Education 2018, Boston, MA. O. Attarabeen, I. Patel, M. Rudolph, H. G. Anderson, K. Broedel-Zaugg, C. Jones, H. Koc, C. Gaither, F Khan. Pharmacy Students’ Perceived Stress and its Impact on Academic Performance in a Flipped Classroom Environment.
  4. July 15-19, 2017. AACP Annual Meeting, Pharmacy Education 2017, Nashville, TN. M. O. Faruk Khan, B. L. Tekwani, Timothy J. Hubin. Discovery of metal complexes of aryl-monocyclic polyamines as new class of antitrypanosomal drug leads.
  5. July 15-19, 2017. AACP Annual Meeting, Pharmacy Education 2017, Nashville, TN. Mohammad F Hossain; Shoshi Chowdhury; M. Omar F. Khan. Optimization of Colorimetric β -Hematin Formation Assay Method for Antimalarial Drug Leads Screening.
  6. Nov 13-17, 2016. AAPS Annual Meeting and Exposition 2016, Colorado Convention Center, Denver, CO. T. J. Hubin, P. Amoyaw, M. F. Hossain, S. Jain, B. L. Tekwani, M. O. F. Khan. Tetraazamacrocyclic Derivatives and Their Metal Complexes as Antileishmanial Leads: Monocyclic Polyamine Derivatives.
  7. July 23-27, 2016. AACP Annual Meeting, Pharmacy Education 2016, Anaheim, CA. M. F. Hossain; H. S. Saluja, M. O. F. Khan. Evaluation of the Physicochemical Properties of a Novel Antimalarial Drug Lead, Cyclen Bisquinoline.
  8. July 23-27, 2016. AACP Annual Meeting, Pharmacy Education 2016, Anaheim, California. M. Omar F. Khan, Marshall University; Jennifer Keiser; Timothy J Hubin. Discovery of antischistosomal drug leads based on macrocyclic polyamine derivatives and their metal complexes.
  9. April 14, 2015. SWOSU Research Day, Southwestern Oklahoma State University, Weatherford, OK. Hossain MF and Khan MOF. Development and Validation of the Stability Indicating Test Method to Determine the Content of Salmeterol Xinafoate and its Organic Impurities in Pharmaceutical Inhaler Dosage Form by RP-HPLC.
  10. March 13, 2015. Oklahoma Research Day, Northeastern State University, OK. Rudraraju A, Hossain MF and Khan MOF. Towards the Synthesis of N4O2-Type Metal Complexes of Antimalarial Macrocyclic Polyamine Ligands.
  11. March 13, 2015. Oklahoma Research Day, Northeastern State University, OK. Rudraraju A, Hossain MF and Khan MOF. UV-Metric, pH-Metric and RP-HPLC Methods to Evaluate the Multiple pKa Values of a Polyprotic Basic Novel Antimalarial Drug Lead, Cyclen Bisquinoline.
  12. November 5, 2014. Hossain MF, Rudraraju A, Shrestha A, Saluja H, Khan MOF. AAPS Annual Meeting and Exposition San Diego, California. Evaluation of the Physicochemical Properties of a Novel Antimalarial Drug Lead, Cyclen Bisquinoline.
  13. November 3, 2014. AAPS Annual Meeting and Exposition San Diego, CA. Hossain MF, Rudraraju A, Shrestha A, Khan MOF. In Vitro Metabolic Stability Study of New Cyclen Based Antimalarial Drug Leads Using RP-HPLC and MS.
  14. April 15, 2014. SWOSU Research Day, Southwestern Oklahoma State University, Weatherford, OK. T.J. Hubin, P.A. Amoyaw, S.J. Archibald, Shabana I. Khan, B.L. Tekwani, M.O. Faruk Khan. Antimalarial Activity of Metal Complexes of Cross Bridged Tetraazamacrocyclin Ligands.
  15. April 15, 2014. SWOSU Research Day, Southwestern Oklahoma State University, Weatherford, OK. T.J. Hubin, P.A. Amoyaw, K. Pham, Shabana I. Khan, S. Jain, S.J. Archibald, B.L.Tekwani, M.O. Faruk Khan. Macrocyclic Polyamine Derivatives and their Metal Complexes as Antileishmanial Leads.
  16. April 15, 2014. SWOSU Research Day, Southwestern Oklahoma State University, Weatherford, OK. A. Rudraraju, A. Shrestha, P. Amoyaw, M.O. Faruk Khan. Metabolic Stability Study of New Cyclen Based Antimalarial Drug Leads Using RP-HPLC.
  17. April 15, 2014. SWOSU Research Day, Southwestern Oklahoma State University, Weatherford, OK. P. Amoyaw, J. Dittrich, A. Rudraraju, Shabana I. Khan, B.L. Tekwani, M.O. Faruk Khan. Cyclen Based Novel Antimalarial Agents: In Vitro and In Vivo Preclinical Studies.
  18. April 15, 2014. SWOSU Research Day, Southwestern Oklahoma State University, Weatherford, OK. A. Rudraraju, P. Amoyaw, T.J. Hubin, M.O. Faruk Khan. Determination of Log P Values of New Cyclen Based Antimalarial Drug Leads Using RP-HPLC.
  19. March 7, 2014. Oklahoma Research Day, University of Central Oklahoma, Edmond, OK. T.J. Hubin, P.A. Amoyaw, S.J. Archibald, Shabana I. Khan, B.L. Tekwani, M.O. Faruk Khan. Antimalarial Activity of Metal Complexes of Cross Bridged Tetraazamacrocyclin Ligands.
  20. March 7, 2014. Oklahoma Research Day, University of Central Oklahoma, Edmond, OK. T.J. Hubin, P.A. Amoyaw, K. Pham, Shabana I. Khan, S. Jain, S.J. Archibald, B.L.Tekwani, M.O. Faruk Khan. Macrocyclic Polyamine Derivatives and their Metal Complexes as Antileishmanial Leads.
  21. March 7, 2014. Oklahoma Research Day, University of Central Oklahoma, Edmond, OK. A. Rudraraju, A. Shrestha, P. Amoyaw, M.O. Faruk Khan. Metabolic Stability Study of New Cyclen Based Antimalarial Drug Leads Using RP-HPLC.
  22. March 7, 2014. Oklahoma Research Day, University of Central Oklahoma, Edmond, OK. P. Amoyaw, J. Dittrich, A. Rudraraju, Shabana I. Khan, B.L. Tekwani, M.O. Faruk Khan. Cyclen Based Novel Antimalarial Agents: In Vitro and In Vivo Preclinical Studies.
  23. March 7, 2014. Oklahoma Research Day, University of Central Oklahoma, Edmond, OK. A. Rudraraju, P. Amoyaw, T.J. Hubin, M.O. Faruk Khan. Determination of Log P Values of New Cyclen Based Antimalarial Drug Leads Using RP-HPLC.
  24. January 12 – 16, 2014. AACP Academic Research Fellows Program, Session II, Tucson, AZ. (Workshop on Leading and Advancing Team Science Program)
  25. November 10-14, 2013. 2013 AAPS annual meeting and exposition, San Antonio, TX. P. Amoyaw, J. Dittrich, A. Rudraraju, Shabana I. Khan, Babu Tekwani, M. O. Faruk Khan. Cyclen Based Novel Antimalarial Agents: In Vitro and In Vivo Preclinical Studies. (Poster)
  26. November 10-14, 2013. 2013 AAPS annual meeting and exposition, San Antonio, TX. T. J. Hubin, P.A. Amoyaw, Stephen J. Archibald, Shabana I. Khan, B. L. Tekwani, M. O. Faruk Khan. Antimalarial activity of metal complexes of cross-bridged tetraazamacrocyclic ligands.(Poster)
  27. November 10-14, 2013. 2013 AAPS annual meeting and exposition, San Antonio, TX. Timothy J. Hubin, Prince A. Amoyaw, Ken Pham, Surendra Jain, Stephen J. Archibald, Babu L. Tekwani, M. Omar F. Khan. Macrocyclic Polyamine Derivatives and their Metal Complexes as Antileishmanial Leads. (Poster)
  28. November 10-14, 2013. 2013 AAPS annual meeting and exposition, San Antonio, TX. A. Rudraraju, P. Amoyaw, M.O. Faruk Khan. Determination of Log P Values of New Drug Leads Using RP-HPLC. (Poster)
  29. September 09 – 13, 2013. AACP Academic Research Fellows Program, Session I, Washington, DC. (Workshop on Leading and Advancing Team Science Program)
  30. May 20-22, 2012. 2013 Central Region IDeA Conference, Kansas City, MO. Antimalarial Activity of Metal Complexes of Cross-bridged Tetraazamacrocyclic Ligands. Timothy J. Hubin, Prince A. Amoyaw, Terence Tanjong, Stephen J. Archibald, Babu L. Tekwan, M. Omar F. Khan. (poster presentation)
  31. May 20-22, 2013. 2013 Central Region IDeA Conference, Kansas City, MO. Cyclen Based Novel Antiparasitic Agents: In vitro and in vivo preclinical studies. P Amoyaw, J Dittrich, BL Tekwani, MOF Khan. (poster presentation)
  32. April 16, 2013. SWOSU Research Day. Novel Cyclen Based Antimalarials: Synthesis and in vitro Metabolism Studies. Terence N. Tanjong;  P. Amoyaw; C. Barnett; Babu L. Tekwani; M. O. Faruk. Khan. Poster presentation by undergraduate student.
  33. April 16, 2013. SWOSU Research Day. Novel Cyclen Based Antimalarials: in vitro and in vivo preclinical studies. Josiah Dittrich, Terence N. Tanjong; P. Amoyaw; Babu L. Tekwani; M. O. Faruk. Khan. Poster presentation by undergraduate student.
  34. April 11, 2013. Research Day at the Capital, Oklahoma State Capital, Oklahoma. Novel Cyclen Based Antimalarials: Synthesis and in vitro Metabolism Studies. Terence N. Tanjong;  P. Amoyaw; C. Barnett; Babu L. Tekwani; M. O. Faruk. Khan. Poster presentation by undergraduate student to represent SWOSU. (Awarded Second Prize among all regional universities and colleges)
  35. March 08, 2013. Oklahoma Research Day. Novel Cyclen Based Antimalarials: Synthesis and in vitro Metabolism Studies. Terence N. Tanjong;  P. Amoyaw; C. Barnett; Babu L. Tekwani; M. O. Faruk. Khan. Poster presentation by undergraduate student.
  36. October 14-18, 2012. AAPS Annual Meeting, Chicago, IL. The antedrug strategy for safer locally active glucocorticoids without suppression of HPA axis. MOF Khan and HJ Lee. (poster presentation)
  37. October 14-18, 2012. AAPS Annual Meeting, Chicago, IL. Novel cyclen based antimalarials: synthesis and in vitro metabolism studies. P. Amoyaw; C. Barnett; T. Tanjong; Babu L. Tekwani; M. O. Faruk Khan. (poster presentation)
  38. July 14-16, 2012. AACP Annual Meeting, Kissimmee, FL. Cyclen Based Novel Antiparasitic Agents: Regioselective synthesis of 4,10-bis(7-chloroquinoline)-1,7-dimethyl-1,4,7,10-tetraazadodecane. P Amoyaw, C Burnett, A Philip, BL Tekwani; RF Borne, MOF Khan. (poster presentation)
  39. June 25-27, 2012. National IDeA Symposium on Biomedical Research Excellence, Washington D.C. Cyclen Based Novel Antiparasitic Agents. P. Amoyaw, C Burnett, T Martin, BL Tekwani, RF Borne, MOF Khan, (poster presentation)
  40. June 20-22, 2012. NIH Regional Seminar on Program Funding & Grant Administration, Washington, D.C.
  41. June 16-17, 2010. Encouraging Development of Therapeutics for Neglected Diseases, Philadelphia, PA. Cyclen Based Novel Antiparasitic Agents, MOF Khan, MW Cochran, BL Tekwani, RF Borne (poster presentation)
  42. Sep 9-12, 2009. 2009 AACP Curricular Change Summit, Scottsdale Resort and Conference center. Participant as a Curriculum Committee Team Member from SWOSU.
  43. Aug 17-21, 2008. American Chemical Society 236th National Meeting & Exposition, Philadelphia, PA. MA Musa, MOF Khan, JS Cooperwood. The synthesis and biological evaluation of coumarin-estrogen conjugates as potential antiproliferative agents. (poster presentation)
  44. March 14, 2008. Missouri Valley Branch of the American Society of Microbiology at William Jewell College in Liberty, Missouri. A Aspedon, MOF Khan, MA Musa. Antibacterial activity of novel bisphenol amines. (poster presentation)
  45. May 10-12, 2007. FLACS (American Chemical Society – Florida Section) Florida Annual Meeting and Exposition, Orlando, FL. MA Musa, JS Cooperwood, MOF Khan. The synthesis and biological evaluation of coumarin-estrogen conjugates as potential anti-breast cancer agents. (poster presentation)
  46. Nov 811, 2006. Annual Biomedical Research Conference for Minority Students (ABRCMS), Anaheim Conference Center and Anaheim Marriott, CA. MOF Khan, KK Park, HJ Lee. New Anti-inflammatory Steroidal Antedrugs: The 21-Thioalkylether and 17-Alkylester Derivatives of 16-Prednisolone Carboxylates (poster presentation). Selected as outstanding presentation.
  47. April 24-26, 2006. AAPS (American Association of Pharmaceutical Scientist) Conference on Critical Issues in Discovering Quality Clinical Candidates, Philadelphia, PA. MOF Khan, K-K Park, HJ Lee. Strategies of Structural Modifications for Safer Therapeutic agents: Antedrugs. (poster presentation)
  48. April 24-26, 2006. IBC Life Science Drug Discovery and Development Summit, Tokyo, Japan. HJ Lee, MOF Khan, K-K Park. A novel approach to potent, yet safer drugs: antedrugs (oral presentation by H.J. Lee).
  49. March 26-30, 2006.231st ACS National Meeting, Atlanta, GA. MOF Khan, K-K Park, HJ Lee. Synthesis and biological evaluation of 21-thioalkylether derivatives of methyl 16-prednisolone carboxylates as a new class of anti-inflammatory steroidal antedrugs. (Oral presentation).
  50. April 6-8, 2005. The 20th RCMI (Research Center in Minority Institutes) Annual Spring Simposium. Houston, Texas. MOF Khan, KK Park, HJ Lee. Antedrugs: an approach to safer drugs. (poster presentation)
  51. September 5, 2003. 3rd Annual Meeting of the Consortium for Antimalarial Development, New Orleans, Louisiana, USA. Synthesis of isoquinuclidine analogues as antimalarial agents. (oral presentation)
  52. September 5, 2003. 3rd Annual Meeting of the Consortium for Antimalarial Development, New Orleans, Louisiana, USA. Synthesis and antimalarial activity of cyclen analogues. (oral presentation)
  53. December 7, 2000. British Pharmaceutical Conference, Barmingham (UK). ‘Medicines- the future horizon’. MOF Khan, SE Austin, C Chan, H Kendrick, V Yardley, SL Croft and KT Douglas. Rational drug design of antitrypanosomal drug leads: Improved trypanothione reductase inhibitors). (poster presentation)
  54. September 11-13, 1998. Fourth European Congress of Pharmaceutical Sciences, Milan, Italy. MOF Khan, SE Austin, C Chan, H Yin, D Marks, SN Vaghjiani, H Kendrick, V Yardley, SL Croft, KT Douglas. Rational design of second generation improvements of tricyclic lead inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs. (poster presentation) (Awarded the best poster)
  55. April 1-4, 1997. International Conference on Improving Use of Medicines: State of the Art and Future Directions, Chiang Mai, Thailand. AKA Chowdhury, MOF Khan, MA Matin, K Begum, MA Gulib. Effect of standard treatment guidelines with or without adult on prescribing for acute respiratory infections in government health facilities in Bangladesh (oral presentation).

3.         Invited Lectures/Seminars

  1. April 19, 2018. Invited seminar on “Macrocylic Polyamine Based Drug Discovery Against Multiple Diseases”. Graduate Seminar Series: Department of Biomedical and Medicinal Chemistry, University of Toledo.
  2. November 25-27, 2015. Promoting Reverse Engineering Technology in Bangladesh. Workshop conducted to the faculty, students and industry personnel at Department of Pharmaceutical Technology, University of Dhaka, Bangladesh.
  3. January 5, 2012. A seminar at Jahangir Nagar University, Dhaka, Bangladesh on “Transitioning to the Doctor of Pharmacy Degree.” It was a two-hour lecture that discussed topic on evolution of the pharmacy profession; roles played by pharmacist, future vision of pharmacist (Appendix A), pharmacy education and accreditations standards in the USA and focused on Appendices B, C and D. Also gave an outline on future of pharmacy profession in Bangladesh and a proposal for Jahangir Nagar University.
  4. January 3, 2012. A seminar at the University Of Development Alternative, Dhaka, Bangladesh. A keynote speech delivered on “Transitioning to the Doctor of Pharmacy Degree.” It was a two hour lecture that discussed topic on evolution of the pharmacy profession; roles played by pharmacist, future vision of pharmacist (Appendix A), pharmacy education and accreditations standards in the USA and focused on Appendices B, C and D. Also gave an outline on future of pharmacy profession in Bangladesh and a proposal for UODA.
  5. January 2009. Antiparasitic, anti-inflammatory, and antibreast cancer drug discovery by rational, combinatorial and antedrug approaches. School of Pharmacy, Chicago, IL.
  6. June 2006. Antiparasitic, and anti-inflammatory drug discovery by rational, combinatorial and antedrug approaches. Midwestern University College of Pharmacy, Glendale, AZ.
  7. February 2006. Drug Design and Discovery Approaches for Parasitic, CNS and Inflammatory Diseases. ILR College of Pharmacy, Texas A&M University, Kingsville, TX.
  8. January 2006. Antiparasitic, and anti-inflammatory drug discovery by rational, combinatorial and antedrug approaches. College of Pharmacy, Temple University, Philadelphia, PA
  9. February 24, 2005. Graduate Seminar Series. College of Pharmacy, Florida A & M University, Tallahassee, FL 32307. Anti-trypanosomal and anti-leishmanial drug design based on trypanothione reductase as a target.

4.         Membership/Leadership In Professional Societies

  • Nominated for Chair Elect for Chemistry Section of AACP (2017)
  • Nominated for Chair Elect position for the DDDi section of AAPS (2014)
  • American Association of College of Pharmacy (2007-2008; 2012- present)
  • American Association of Pharmaceutical Scientists (2005 – 2008; 2012 – present)
  • American Chemical Society, (2005 – 2010)
  • American Association of Bangladeshi Pharmaceutical Scientists (2008-present)
  • Elected joint secretary of the Pharmacy Graduates’ Association of Bangladesh (PGA) (1999)
  • President of the Bangladesh Students Society, Manchester, UK (1997 – 1998).
  • Elected executive council member of the PGA (1990 – 1995).

5.         Publications

A. Book & Book Chapters:

  1. MOF Khan and Ashok Philip, Medicinal Chemistry for Pharmacy Students, Volume 1: Fundamentals of Medicinal Chemistry and Drug Metabolism, 2018; Bentham Scientific Publishers.
  2. MJ Deimling, MOF Khan, GR Ortega. Vitamins (Chapter 28), in Wilson and Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry, Twelfth Edition, 2010, Lippincott Williams & Wilkins.
  3. MOF Khan, MS Levi, CR Clark, SY Ablordeppey, S-J Law, NH Wilson and RF Borne, Isoquinuclidines: A Review of Chemical and Pharmacological Properties. In Book Series: Studies in Natural Product Chemistry,v 34, 2008, Atta-ur-Rahman Eds. Elsevier BV, Amsterdam, Netherlands. p 753-787.
  4. Medicinal Chemistry for Pharmacy Students Volume 2 -4 under preparation. Publisher: Bentham Scientific Publishers.

B. CE Article/ News Letter:

  1. MOF Khan, WS. Pray. Why patients need protection from sun? U.S. Pharmacist (Consult your Pharmacist) 34(7), 14-19. (July 2009).
  2. AKA Chowdhury, MOF Khan, MA Matin, Z Haque. Impact of standard treatment guidelines and small group training on prescribing for diarrhoea in under-five children in Bangladesh. INRUD News 5(2) 20 (1996). (International Network for Rational Use of Drugs’ News Letter).
  3. AKA Chowdhury, MOF. Khan, MA. Matin, A Haque, AL Bhuiya. Effect of standard treatment guidelines with or without audit on prescribing for acute respiratory infections in government health facilities in Bangladesh. INRUD News Letter, 1995 (Report).

 

 

C. Peer Reviewed Journal Articles:

  1. Feng X, Turley J, Xie Z, Pierre SV, Koc H, Khan MO, Hao J. (2017) An LC-MS/MS method for the determination of digitoxigenin in skin samples and its application to skin permeation and metabolic stability studies. J Pharm Biomed Anal. 2017 May 10;138:378-385. doi: 10.1016/j.jpba.2016.12.029. Epub 2016 Dec 23.
  2. Hossain MF, Amoyaw PNA, Saluja HS, Khan FMO (2016) Evaluation of the Physicochemical Properties of a Novel Antimalarial Drug Lead, Cyclen Bisquinoline. Mod Chem appl 4: 181. doi:  10.4172/2329-6798.10001.
  3. M. O. Faruk Khan,* Jennifer Keiser, P. N. A. Amoyaw, Mohammad F. Hossain, Mireille Vargas, Justin G. Le, Natalie C. Simpson, Kimberly D. Roewe, TaRynn N. Carder Freeman, Travis R. Hasley, Randall D. Maples, Stephen J. Archibald, Timothy J. Hubin. Discovery of antischistosomal drug leads based on tetraazamacrocyclic derivatives and their metal complexes. Antimicrob. Agents Chemother. 60:5331–5336; Accepted manuscript posted online 20 June 2016, doi:10.1128/AAC.00778-16
  4. PNA Amoyaw, K Pham, AN Cain, JM McClain, TJ Hubin, MOF Khan. (2014). Synthesis of novel tetraazamacrocyclic bisquinoline derivatives as potential antimalarial agents. Curr. Org. Synth.11(6):916-921. (IF: 2.914)
  5. AV Rudraraju, PNA Amoyaw, TJ Hubin, MOF Khan. Determination of Log P Values of New Cyclen Based Antimalarial Drug Leads Using RP-HPLC. Die Pharmazie, 69, 655–662 (2014). (IF: .962)
  6. TJ Hubin, PNA Amoyaw, KD Roewe, NC Simpson, RD Maples, TNC Freeman, AN Cain, JG Le, SJ Archibald, SI Khan, BL Tekwani, MOF Khan. (2014). Synthesis and antimalarial activity of metal complexes of cross-bridged tetraazamacrocyclic ligands. Bioorg. Med. Chem., 22:3239–3244 (2014); (Online: http://dx.doi.org/10.1016/j.bmc.2014.05.003). (IF: 3.15; Cit. 1)
  7. AV Rudraraju, A Shrestha, PNA Amoyaw, BL Tekwani, MOF Khan. (2014). In vitro metabolic stability study of new cyclen based antimalarial drug leads using RP-HPLC and LC-MS/MS. Modern Chem Appl. 2: 129. doi:10.4172/2329-6798.1000129. (New Peer Reviewed Journal)
  8. MOF Khan, C. L. Ramos. An Update on BRAF Inhibitors and Other New Molecular Targets for the Treatment of Malignant Melanoma of the Skin. Clin. Med. Insight: Dermatol. (2013) (Editorial Review) (IF: New Journal; Cit. 1)
  9. MOF Khan, MJ Deimling, A Philip. Medicinal Chemistry and the pharmacy Curriculum. Am. J. Pharm. Edu. (2011);75(8) Article 161. (IF: 1.30; Cit. 1)
  10. MA Musa, J